TEMAZEPAM capsule

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

TEMAZEPAM (UNII: CHB1QD2QSS) (TEMAZEPAM - UNII:CHB1QD2QSS)

Available from:

Aphena Pharma Solutions - Tennessee, LLC

Administration route:

ORAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Temazepam Capsules, USP are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that Temazepam Capsules, USP should be used for short periods of time (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment. Benzodiazepines may cause fetal harm when administered to a pregnant woman. An increased risk of congenital malformations associated with the use of diazepam and chlordiazepoxide during the first trimester of pregnancy has been suggested in several studies. Transplacental distribution has resulted in neonatal CNS depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy. Reproduction studies in animals with temazepam were performed in rats and rabbits. In a perinatal-postnatal study in rats, oral doses of 60 mg/

Product summary:

Temazepam Capsules USP 7.5 mg Pink opaque cap and white opaque body, imprinted “7.5 mg” on cap and “Novel 120” on the body in black ink. Unit dose box of 30........NDC 0904-6436-04 Bottle of 100 ……..NDC 0904-6436-60 Dispense in a well-closed, light-resistant container with a child-resistant closure. Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. *Romazicon is the registered trademark of Hoffman-LaRoche Inc. **Trademark of Medical Economics Company, Inc. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Distributed by: MAJOR PHARMACEUTICALS 31778 Enterprise Drive Livonia, MI 48150  USA

Authorization status:

Abbreviated New Drug Application

Patient Information leaflet

TEMAZEPAM- TEMAZEPAM CAPSULE
Aphena Pharma Solutions - Tennessee, LLC
----------
MEDGUIDE
TEMAZEPAM Capsules, USP C-IV
(temazepam)
Read the Medication Guide that comes with TEMAZEPAM before you start
taking it and each time you
get a refill. There may be new information. This Medication Guide does
not take the place of talking to
your doctor about your medical condition or treatment.
What is the most important information I should know about TEMAZEPAM?
After taking TEMAZEPAM, you may get up out of bed while not being
fully awake and do an activity
that you do not know you are doing. The next morning, you may not
remember that you did anything
during the night. You have a higher chance for doing these activities
if you drink alcohol or take other
medicines that make you sleepy with TEMAZEPAM. Reported activities
include:
•
driving a car (“sleep-driving”)
•
making and eating food
•
talking on the phone
•
having sex
•
sleep-walking
Call your doctor right away if you find out that you have done any of
the above activities after taking
TEMAZEPAM.
Important:
1.
Take TEMAZEPAM exactly as prescribed
2.
Do not take more TEMAZEPAM than prescribed.
3.
Take TEMAZEPAM right before you get in bed, not sooner.
4.
Do not take TEMAZEPAM if you:
•
drink alcohol
•
take other medicines that can make you sleepy. Talk to your doctor
about all of your medicines.
Your doctor will tell you if you can take TEMAZEPAM with your other
medicines
•
cannot get a full night’s sleep
What is TEMAZEPAM?
TEMAZEPAM is a sedative-hypnotic (sleep) medicine. TEMAZEPAM is used
in adults for the short-
term (usually 7 to 10 days) treatment of a sleep problem called
insomnia. Symptoms of insomnia include:
•
trouble falling asleep
•
waking up often during the night
TEMAZEPAM is not for children.
TEMAZEPAM is a federally controlled substance (C-IV) because it can be
abused or lead to
dependence. Keep TEMAZEPAM in a safe place to prevent misuse and
abuse. Selling or giving away
TEMAZEPAM may harm others, and is against the law. Tell

Summary of Product characteristics

TEMAZEPAM- TEMAZEPAM CAPSULE
APHENA PHARMA SOLUTIONS - TENNESSEE, LLC
----------
TEMAZEPAM CAPSULES, USP
NOVEL LABORATORIES, INC.
RX ONLY
DESCRIPTION
Temazepam is a benzodiazepine hypnotic agent. The chemical name is
7-chloro -1,3-dihydro-3-
hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, and the
structural formula is:
C
H ClN O MW = 300.74
Temazepam is a white, crystalline substance, very slightly soluble in
water and sparingly soluble in
alcohol USP.
Temazepam Capsules, USP, 7.5 mg, 15 mg, 22.5 mg and 30 mg, are for
oral administration.
_7.5 MG, 15 MG, 22.5 MG AND 30 MG CAPSULES_
Active Ingredient: temazepam USP
_7.5 MG CAPSULES_
Inactive Ingredients: Corn starch, lactose anhydrous, magnesium
stearate, sodium lauryl sulfate, FD&C
Red #40 and titanium dioxide.
May also include: sodium lauryl sulfate. Imprinting ink may contain
ammonium hydroxide, ethanol,
isopropyl alcohol, butanol, shellac, potassium hydroxide, propylene
glycol, and black iron oxide.
_15 MG CAPSULES_
Inactive Ingredients: Corn starch, lactose anhydrous, magnesium
stearate, sodium lauryl sulfate, FD&C
Blue #1, FD&C yellow # 6, gelatin and titanium dioxide.
May also include: sodium lauryl sulfate. Imprinting ink may contain
ammonium hydroxide, ethanol,
isopropyl alcohol, butanol, shellac, potassium hydroxide, propylene
glycol, and black iron oxide.
_22.5 MG CAPSULES_
Inactive Ingredients: Corn starch, lactose anhydrous, magnesium
stearate, sodium lauryl sulfate, FD&C
Blue #1, FD&C Red #40, gelatin and titanium dioxide.
May also include: sodium lauryl sulfate. Imprinting ink may contain
ammonium hydroxide, ethanol,
isopropyl alcohol, butanol, shellac, potassium hydroxide, propylene
glycol, and black iron oxide.
_30 MG CAPSULES_
Inactive Ingredients: Corn starch, lactose anhydrous, magnesium
stearate, sodium lauryl sulfate, gelatin
and titanium dioxide.
May also include: sodium lauryl sulfate. Imprinting ink may contain
ammonium hydroxide, ethanol,
isopropyl alcohol, butanol, shellac, potassium hydroxide, propylene
glycol, and black iron oxid